Clinical Trial Update: Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a transgenic lymphocyte immunization vaccine for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Transgenic Lymphocyte Immunization Vaccine

Snippet

Sponsor: Cosmo Bioscience | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED